Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide for menstrual migraine exacerbation despite prophylaxis
IRCT20161103030680N8Phase 3Completed
- Sponsor
- Shahed University
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Catamenial Migraine and migraine comparing Acetazolamide add-on with Placebo add-on (2 arms). Primary endpoints: Headache intensity, Headache frequency and 1 more. Started Aug 2013; status: completed.
02
Drugs
acetazolamide
03
Conditions
Catamenial Migrainemigraine
Beyond the preview
Go deeper on IRCT20161103030680N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161103030680N8.